Navigation Links
Age Matters in Kidney Matching

Over the years kidney transplantation has come a long way. The number of successfully transplanted kidneys has been able to help more and more people lead a normal lifestyle. //However, a recent study looking into the issue, “If Age matters when matching donor and recipient kidneys,” gave not only the researchers a whole new perspective but also the transplant community.

Researchers from the University of Florida in Gainesville found that, pairing young kidneys with young recipients could actually potentially extend a young patient's life by more than two years.

According to this new study, researchers examined more than 74,000 deceased-donor kidney transplants between 1990 and 2002. They found that if donors between the ages of 15 and 50 were matched with recipients under the age of 60, and if kidneys of donors 50 years and older were matched with patients over age 60 then the life expectancy of each transplant patient’s life would increase by an average of nine months, with the transplanted kidney lasting an additional three years.

'"/>




Page: 1

Related medicine news :

1. Money Matters When Choosing an Infertility Treatment
2. India -Penny Wise and Pound Foolish on Health Matters
3. Is Diabetes the Leading Cause of Kidney Failure in India
4. Kidney Stones - Interesting New Research implicates bacteria as its cause
5. Moderate Use of Analgesics - Not Associated With Kidney Dysfunction
6. New Dietary Approach To Manage Kidney Stones
7. Kidney cancer on the rise
8. Kidney function can be affected by lead exposure
9. Kidney Failure after Non-Kidney Transplants
10. Kidney Patients Risk Heart Attacks
11. Kidney Patients Risk Heart Attacks
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Age Matters Kidney Matching

(Date:5/12/2008)...on, ON (May 12, 2008) - Beta-blocker drugs may hel...ay increase the risk of death and major stroke, sa...he prestigious medical journal, The Lancet. , PO...ing perioperative cardiac complications. POISE ev...bo given to patients around the time of surgery. ...
(Date:5/12/2008)..., China, May 12 /Xinhua-PRNewswire-FirstCall/ -- C...rd: CYXI) ("China Yingxia" or "the,Company"), a le...ed in the,development, manufacture and distributio...s, and personal care products in the People,s Repu...duct a conference call,Friday, May 16, 2008, at 1...
(Date:5/12/2008)...LE, N.Y., May 12 /PRNewswire/ -- Fairbank Farms, a...tary recall of selected ground beef,products produ...gh Price,Chopper, Shaw,s, BJ,s, and Wilson Farms r... affected product may contain small pieces of hard...l-by" date of 05/13/08, 05/15/08, or a,"Julian dat...
(Date:5/12/2008)...IN VIEW, Calif., May 12 /PRNewswire-FirstCall/ -- ...nnounced financial results for,the first quarter e...quarter ended March 31, 2008 was $14.3,million com...2007. As of,March 31, 2008, MAP Pharmaceuticals ha...s of $81.1 million., First Quarter Financial Resu...
Breaking Medicine News(10 mins):Health News:Metoprolol around the time of surgery increases the risk of death and stroke: POISE trial 2Health News:Metoprolol around the time of surgery increases the risk of death and stroke: POISE trial 3Health News:China Yingxia International, Inc. Announces Conference Call to Discuss First Quarter 2008 Results 2Health News:Fairbank Farms Issues Voluntary Recall for Selected Ground Beef Products 2Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 2Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 3Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 4Health News:MAP Pharmaceuticals Reports First Quarter of 2008 Financial Results 5
...h 50 ballpoint pens a week has been cured by hypno...a month on his habit after he was banned// from us...uld find anything to write with. “My manager took...oney I was costing them but the fact that nobody e...
... television for long hours are more likely to be ...ohnson, of Columbia University// and the New York ... than 700 children through adolescence to adulthoo...ed one or more hours of television a day appeared ...
...gitis C vaccine into the UK has not only reduced t...people, but has done so cost-effectively.// Resear...gitis C campaign in young people up to the age of ...’s introduction in December 1998, meningitis C aff...
...ug Administration agreed that an ingredient common...e, and it plans to recommend further review by the...ittee met to discuss a new five-year study by Yale...nyl-propanolamine (PPA), an active ingredient in n...
Other Medicine News:
(Date:5/12/2008)...ercell AG (,Intercell,) to acquire Iomai Corporati...ansaction for USD 6.60 per share of Iomai,s comm... of Iomai of approximately USD 189 million (EUR ...ugh stock-for-stock exchange for approximately 41 ...d by major shareholders for,approximately 1.7 mill...
(Date:5/12/2008)... ARBOR, Mich., May 12 /- Velcura Ther... of a first-in-man clinical trial for,its lead com...g as a,treatment for Rheumatoid Arthritis (RA) and...dies, VEL-0230 proved to be a powerful,anti-inflam...nd inhibits,bone loss. Taken together, these chara...
(Date:5/12/2008)...ANTA, May 12 /- CryoLife, I...and tissue processing company, today announced,the...al allograft heart,valve in a patient at the Cleve... Navia, a cardiac surgeon with the Heart and Vascu...d used to process the combination aortic-mitral hu...
(Date:5/9/2008)...A, Fla., May 9 /PRNewswire-USNewswire/ -- Osteoart...ondition that affects almost 50,million people in ...f,cartilage in bone joints. The novel investigatio... oral analgesic, provided significant relief,for p... treated with,placebo, and with fewer gastrointest...
Breaking Medicine Technology:Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 2Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 3Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 4Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 5Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 6Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 7Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 8Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 9Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 10Intercell AG to Acquire Iomai Corporation to Expand Late Stage Product Pipeline and Strengthen Leadership in Vaccine Innovation 11Velcura Therapeutics, Inc. Reports Successful Phase 1 Clinical Trial of Novel Bone Disease Therapy 2CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic 2CryoLife Announces First Implant of Combination Aortic-Mitral Allograft Heart Valve at the Cleveland Clinic 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5Congressional Budget Includes Earmark to Keep Washingtons Sexual Assault DNA Program Moving Forward 9380 1Congressional Budget Includes Earmark to Keep Washingtons Sexual Assault DNA Program Moving Forward 9380 2Crdentia Appoints Debbie Griffith to Director of Business Development Reporting Directly to CEO 9377 1Crdentia Appoints Debbie Griffith to Director of Business Development Reporting Directly to CEO 9377 2Seven Summits Research Releases Alerts on XOM MER DRYS CSC and PDLI 2546 1Seven Summits Research Releases Alerts on XOM MER DRYS CSC and PDLI 2546 2Seven Summits Research Releases Alerts on XOM MER DRYS CSC and PDLI 2546 3SciQuest Continues to Surpass Milestones for Customer Wins Growth and Market Share 3B Remains Clear Eprocurement Leader for Academic and Research Cen 2543 1SciQuest Continues to Surpass Milestones for Customer Wins Growth and Market Share 3B Remains Clear Eprocurement Leader for Academic and Research Cen 2543 2SciQuest Continues to Surpass Milestones for Customer Wins Growth and Market Share 3B Remains Clear Eprocurement Leader for Academic and Research Cen 2543 3SciQuest Continues to Surpass Milestones for Customer Wins Growth and Market Share 3B Remains Clear Eprocurement Leader for Academic and Research Cen 2543 4
...sented at 12th Congress of European Hematology -, ...ll/ -- Alexion,Pharmaceuticals, Inc. today announc...s examining Soliris(TM) (eculizumab) for the,treat...at the 12th,Congress of European Hematology, organ...in Vienna. These presentations,included: , "The Te...
...NDS, Texas--(BUSINESS WIRE)--Jun 11, 2007 - Opexa,...ed in the,development and commercialization of cel...7 Annual Meeting of the Federation of,Clinical Imm...t the,Sheraton San Diego Hotel & Marina. The p...elin Peptides in Relapsing,Remitting Multiple Scle...
Other Medicine Technology:Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients 2Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients 3Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients 4Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients 5Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients 6Studies Show Efficacy and Safety of Alexion's Soliris in Broad,Population of PNH Patients 7Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 2Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 3Opexa Presents Tovaxin Research at Federation of Clinical,Immunology Societies Annual Meeting 4
The knee is the body's largest and most complicated joint. Repetitive or inappropriate stresses caused by sports or work often lead to excessive strain. Zeuba Vital Knee Support reinforces the knee j
SofTec Genu is the first functional brace that provides full soft tissue control, enhances natural muscle movement, prevents atrophy, increases proprioception and controls A/P laxity.
Comprifix Knee is a comfortable, lightweight, anatomically knitted knee support with an incorporated donut shaped insert for the reduction of pain and swelling.
McDavid® Patella Knee Support helps relieve the symptoms of chondromalacia patellar subluxation and patellar tendonitis. Features two medial and two lateral spring-steel stays. 3/16" thick neopre
Medicine Products: